Related Experiment Videos
The International Society for Immunohistochemistry and Molecular Morphology (ISIMM)
1Keck School of Medicine at University of Southern California, Los Angeles, CA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2025
A Consortium for Analytic Standardization in Immunohistochemistry.
Archives of pathology & laboratory medicine·2022
New Dimensions of Antigen Retrieval Technique: 28 Years of Development, Practice, and Expansion.
Applied immunohistochemistry & molecular morphology : AIMM·2019
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.
Applied immunohistochemistry & molecular morphology : AIMM·2019
Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).
The American journal of surgical pathology·2017
Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical Method.
Applied immunohistochemistry & molecular morphology : AIMM·2017
Neuroendocrine Differentiation in Synovial Sarcoma-An Immunohistochemical Study of 357 Tumors With 4 Markers: Chromogranin A, Synaptophysin, Insulinoma-associated Protein 1 and Insulin Gene Enhancer Protein ISL-1.
Applied immunohistochemistry & molecular morphology : AIMM·2026
Profiling NFκB and VEGF Expression in Mouse Embryonic Stem Cells, Lung Cancer Cells, and Fibroblasts.
Applied immunohistochemistry & molecular morphology : AIMM·2026
PRAME Expression in Merkel Cell Carcinoma: Correlation With MCPyV Status, PD-L1, and Tumor-Infiltrating Lymphocytes in a Multicenter Cohort.
Applied immunohistochemistry & molecular morphology : AIMM·2026
Immunohistochemistry Assay Based on Ready-To-Use Antibodies and Vendor-Recommended Protocol Settings Often Perform Suboptimally.
Applied immunohistochemistry & molecular morphology : AIMM·2026
A Single-Center Comparative Study of the c-MET Immunohistochemistry SP44 and LBP4 Assays in Chinese Non-Small Cell Lung Cancer (NSCLC) Cohort.
Applied immunohistochemistry & molecular morphology : AIMM·2026
Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer.
Applied immunohistochemistry & molecular morphology : AIMM·2026